This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (38)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN P. NICHOLAS, MD

Arch Ophthalmol. 1964;72(2):189-197.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Locally and systemically administered corticosteroids have been implicated as a causative factor in the elevation of intraocular pressure.^1-7 Recently, the extensive studies of Armaly^8,9 and Becker¹⁰ have clearly documented the relationship of corticosteroid medication and the rise of intraocular pressure. The present investigation is a further attempt to elucidate this steroid-induced oculotensive phenomenon.

Material and Methods

Three groups of subjects were studied in the following manner.

Group A. Open-Angle Glaucoma Patients.

—The group comprised 11 patients. Eight were receiving 2% l -epinephrine hydrochloride and three were using pilocarpine. The patients were instructed to use 0.1% dexamethasone topically, one drop four times a day in one eye, while continuing their glaucoma medications in both eyes. Intraocular pressure measurements with the Goldmann Applanation Tonometer and the Mueller Electronic Tonometer were performed along with tonography at varying intervals, usually weekly. If the ocular pressure rose to 28 mm Hg by . . . [Full Text PDF of this Article]

Author Affiliations
Bethesda, Md

From the Ophthalmology Branch, National Institute of Neurological Diseases and Blindness, National Institutes of Health, Public Health Service, Department of Health, Education, and Welfare.

Footnotes
Submitted for publication Feb 3, 1964.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?